TNDM Tandem Diabetes Care Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TNDM

Price (delayed)

$22.32

Market cap

$1.55B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.92

Enterprise value

$2.23B

?
Relative Growth: Rel. Growth: 53
Relative Strength: Rel. Strength: 82
Relative Valuation: Rel. Valuation: 24
Relative Profitability: Rel. Profitability: 40

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities ...

Highlights
Tandem Diabetes Care's EPS has soared by 70% YoY and by 34% from the previous quarter
The net income has soared by 69% YoY and by 33% from the previous quarter
Tandem Diabetes Care's quick ratio has increased by 39% YoY but it has decreased by 15% from the previous quarter
The debt has soared by 65% YoY
The company's equity fell by 2.2% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.tandemdiabetes.com
Peers: PODD ICUI DXCM DCTH

Key stats

What are the main financial stats of TNDM

TNDM stock price

How has the Tandem Diabetes Care stock price performed over time
Intraday
-1.11%
1 week
-1.76%
1 month
26.82%
1 year
101.99%
YTD
1.55%
QTD
47.91%

Financial performance

How have Tandem Diabetes Care's revenue and profit performed over time
Revenue
$1.04B
Gross profit
$583.32M
Operating income
-$45.8M
Net income
-$63.32M
Gross margin
56%
Net margin
-6.1%
The operating margin has soared by 78% YoY and by 46% from the previous quarter
The operating income has soared by 77% YoY and by 45% QoQ
The net margin has soared by 70% YoY and by 34% from the previous quarter
The net income has soared by 69% YoY and by 33% from the previous quarter

Price vs fundamentals

How does TNDM's price correlate with its fundamentals

Growth

What is Tandem Diabetes Care's growth rate over time

Valuation

What is Tandem Diabetes Care stock price valuation
P/E
N/A
P/B
11.73
P/S
1.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.14
Tandem Diabetes Care's EPS has soared by 70% YoY and by 34% from the previous quarter
TNDM's price to book (P/B) is 40% more than its last 4 quarters average of 8.4 and 20% more than its 5-year quarterly average of 9.8
The company's equity fell by 2.2% YoY
The P/S is 61% lower than the 5-year quarterly average of 3.8 but 35% higher than the last 4 quarters average of 1.1
TNDM's revenue is up by 4% year-on-year

Efficiency

How efficient is Tandem Diabetes Care business performance
The return on invested capital has surged by 77% year-on-year and by 48% since the previous quarter
Tandem Diabetes Care's ROS has soared by 74% YoY and by 43% from the previous quarter
The return on assets has surged by 72% year-on-year and by 38% since the previous quarter
TNDM's ROE has soared by 56% YoY and by 33% from the previous quarter

Dividends

What is TNDM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TNDM.

Financial health

How did Tandem Diabetes Care financials performed over time
The total assets is 13% greater than the total liabilities
Tandem Diabetes Care's quick ratio has increased by 39% YoY but it has decreased by 15% from the previous quarter
The total liabilities has grown by 38% YoY
The company's debt to equity has surged by 68% YoY and by 2.2% QoQ
The debt has soared by 65% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.